Related Experiment Video
Updated: May 27, 2026

Integration of 5G Experimentation Infrastructures into a Multi-Site NFV Ecosystem
Published on: February 3, 2021
Another VCP interactor: NF is enough
1Department of Neurology, Washington University School of Medicine, Saint Louis, Missouri 63110, USA. weihlc@neuro.wustl.edu
Abstract:
Inclusion body myopathy with Paget disease of the bone and frontotemporal dementia (IBMPFD) is a multisystem degenerative disorder caused by mutations in the valosin-containing protein (VCP) gene. How missense mutations in this abundant, ubiquitously expressed, multifunctional protein lead to the degeneration of disparate tissues is unclear. VCP participates in diverse cellular functions by associating with an expanding collection of substrates and cofactors that dictate its functionality. In this issue of the JCI, Wang and colleagues have further expanded the VCP interactome by identifying neurofibromin-1 (NF1) as a novel VCP interactor in the CNS. IBMPFD-associated mutations disrupt binding of VCP to NF1, resulting in reduced synaptogenesis. Thus, aberrant interactions between VCP and NF1 may explain the dementia phenotype and cognitive delay observed in patients with IBMPFD and neurofibromatosis type 1.
Insights
Mutations in the VCP gene cause Inclusion body myopathy with Paget disease of the bone and frontotemporal dementia (IBMPFD). This study identifies neurofibromin-1 (NF1) as a novel VCP interactor, revealing how VCP-NF1 interactions impact brain function.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Inclusion body myopathy with Paget disease of the bone and frontotemporal dementia (IBMPFD) is a multisystem disorder linked to mutations in the valosin-containing protein (VCP) gene.
- The precise mechanisms by which VCP mutations cause tissue degeneration remain largely unknown.
- VCP is a multifunctional protein involved in various cellular processes through interactions with numerous substrates.
Purpose of the Study:
- To identify novel VCP interactors in the central nervous system (CNS).
- To investigate the functional consequences of VCP-neurofibromin-1 (NF1) interactions in the context of IBMPFD and related neurological disorders.
Main Methods:
- Proteomic analysis to identify novel VCP interactors.
- Biochemical assays to assess the impact of IBMPFD-associated VCP mutations on VCP-NF1 binding.
- Evaluation of synaptogenesis in relevant cellular or animal models.
Main Results:
- Neurofibromin-1 (NF1) was identified as a novel VCP-interacting protein in the CNS.
- IBMPFD-associated mutations in VCP impair its binding to NF1.
- Disrupted VCP-NF1 interaction leads to reduced synaptogenesis.
Conclusions:
- Aberrant interactions between VCP and NF1 may contribute to the dementia phenotype and cognitive deficits observed in IBMPFD.
- The VCP-NF1 interaction represents a potential therapeutic target for neurological symptoms in IBMPFD and neurofibromatosis type 1.
Related Concept Videos
Interpersonal Psychotherapy
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Pilot and Numeric Relaying
Compacting Factor test
The procedure begins by placing concrete into the upper hopper without any compaction. Once filled, the bottom door of this hopper is opened,...
Interference: Path Lengths
Two special sources may be considered when they are in phase. This can be easily achieved by feeding the two sources from the same source. An example would be synchronizing the two speakers by feeding them with the same source, such as the sound waves produced by a tuning fork. This setup ensures that the two sources have the same frequency and are...

